SternAegis
SternAegis seeks to invest in the technology, telecom, media, internet, and emerging growth sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed SternAegis Information
Geographic Data
Address: 810 7th Ave
City: New York
State: NY
Zip: 10019
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
9,781,596Website Global Rank
100Website Monthly Traffic
Twitter Followers
Description
SternAegis Ventures is a corporate venture arm of Aegis Capital that began operation on January 1, 2012, with its headquarters in New York City. It seeks to invest in the technology, telecom, media, internet, and emerging growth sectors. It offers large firm execution capability with a small firm service approach. It bridges the gap between emerging growth companies and the capital markets by providing investment banking services and principal investment. It is well-equipped to assist in the capital formation of companies seeking to progress from private financing to accessing capital from the public markets.
Contact Phone:
+16465022401
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2021 | Hydrobuilder.com | Venture Round | 60M |
| 9/2021 | Aerami Therapeutics | Venture Round | 22.3M |
| 11/2017 | BackBeat Medical | Venture Round | 4M |
| 4/2013 | DarioHealth | Venture Round | 10M |
| 5/2013 | MATINAS BIOPHARMA | Venture Round | 33M |
| 8/2022 | Clover | Venture Round | 6M |
| 10/2015 | Aerami Therapeutics | Venture Round | 20M |
| 9/2022 | Aerami Therapeutics | Series B | 5.4M |
| 11/2021 | Outstanding Foods | Venture Round | 0 |
| 6/2020 | DermaSensor | Series A | 11.5M |
| 12/2016 | Motus GI | Venture Round | 0 |
| 3/2019 | Orchestra BioMed | Series B | 34M |
| 6/2017 | Calibertherapeutics | Venture Round | 12M |
| 12/2021 | Psudo | Seed Round | 3M |
| 9/2017 | Adgero Biopharmaceuticals | Venture Round | 3.4M |
| 10/2019 | DarioHealth | Post-IPO Equity | 21.3M |
| 10/2011 | InVivo Therapeutics | Post-IPO Equity | 30M |
| 3/2014 | Corbus Pharmaceuticals | Venture Round | 20M |
| 11/2017 | Aerami Therapeutics | Venture Round | 13.9M |
| 7/2021 | ZoomCar | Series E | 0 |
| 8/2018 | Hydrofarm | Venture Round | 29.4M |
| 11/2007 | PROLOR Biotech | Venture Round | 30M |
| 9/2016 | Adgero Biopharmaceuticals | Venture Round | 9.7M |
| 12/2012 | Organovo Holdings | Post-IPO Equity | 25M |
| 3/2020 | Aerami Therapeutics | Venture Round | 12.4M |
| 7/2020 | DarioHealth | Post-IPO Equity | 28.6M |
| 3/2022 | Amplifica | Series A | 11.8M |
| 5/2013 | Deem | Venture Round | 12.5M |
| 4/2020 | Outstanding Foods | Venture Round | 5M |
| 3/2021 | ZoomCar | Series A | 0 |
| 5/2013 | Armada Water Assets | Venture Round | 10M |
| 1/2013 | GlobeImmune | Venture Round | 7.5M |
| 10/2016 | Helocyte | Venture Round | 4M |
| 1/2021 | Outstanding Foods | Series A | 0 |
| 1/2018 | Orchestra BioMed | Venture Round | 22.8M |
| 9/2021 | Aerami Therapeutics | Venture Round | 22.3M |
| 1/2022 | Orchestra BioMed | Series D | 0 |
| 5/2016 | Kintara Therapeutics | Post-IPO Equity | 9.5M |
| 8/2021 | DermaSensor | Series B | 0 |
| 8/2021 | Viscient Biosciences | Convertible Note | 0 |
| 1/2022 | Orchestra BioMed | Series D | 0 |
| 12/2021 | Psudo | Seed Round | 0 |
| 11/2021 | Outstanding Foods | Venture Round | 0 |
| 9/2021 | Aerami Therapeutics | Funding Round | 0 |
| 8/2021 | DermaSensor | Series B | 0 |
| 8/2021 | Viscient Biosciences | Convertible Note | 0 |
| 7/2021 | ZoomCar | Series E | 0 |
| 5/2021 | Hydrobuilder.com | Venture Round | 0 |
| 3/2021 | ZoomCar | Series A | 0 |
| 1/2021 | Outstanding Foods | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
